glp-1 obesity drug news The revolution: What UAB researchers are discovering about how these drugs work The Multi-Sector Impacts of GLP-1RA
Description
Effect of dulaglutide on cognitive impairment in type 2 diabetes: An exploratory analysis of the REWIND trial
venous sinus stenting for idiopathic intracranial hypertension (IIH)] [7], and novel therapeutics (i.e
Regul Pept 2005;125:173177
Glucagon-like peptide-1 (GLP-1) agonists have transformed weight loss treatments
Their comparison offers insight into how two drugs with the same fundamental mechanism can be differentiated through clinical development strategy, formulation, and positioning
